Heart Test Laboratories I... (HSCS)
NASDAQ: HSCS
· Real-Time Price · USD
3.38
-0.12 (-3.43%)
At close: Aug 15, 2025, 2:17 PM
Heart Test Laboratories Cash Flow Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 |
Net Income | -2.09M | -2.54M | -4.13B | -2.05M | -1.85M | -1.64M | -1.75M | -1.37M | -1.63M | -1.34M | -1.81M | -1.57M | -2.05M | -1.24M | -1.03M | -501.85K | -851.57K |
Depreciation & Amortization | 31.26K | 28.97K | 34.41K | 33.32K | 76.44K | 3.72K | 7.64K | 7.34K | 6.83K | 6.87K | 6.81K | 6.41K | 6.5K | 6.5K | 6.6K | 6.97K | 7.25K |
Stock-Based Compensation | 95.94K | 54.82K | 44.56K | 54.55K | 78.45K | 96.09K | 105.84K | 124.65K | 99.16K | 1.51K | 1.92K | 145.72K | -49.85K | 115.83K | 834.00 | 1.58K | 2.82K |
Other Working Capital | 194.83K | 593.48K | 195.06M | 588.00 | -37.41K | -41.63K | -299.85K | 7.13K | -175.92K | 67.53K | 1.59M | -211.71K | 429.36K | 126K | 68.86K | 67.25K | 20.02K |
Other Non-Cash Items | 270.54K | 109.95K | 4.13B | 10.05K | 100K | 906.72K | 315.49K | -1.32B | 151.33K | -230.94K | -81.2K | -19.82K | 180.66K | 32.34K | -176.39K | 1.61K | 1.66K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -1.32B | -782.99K | n/a | 1.32B | n/a | 230.94K | 81.2K | n/a | n/a | n/a | n/a | -250.2K | n/a |
Change in Working Capital | 105.94K | 722.47K | 64.95K | -64.95K | 54.9K | -721.09K | 331.23K | -169.39K | -486.65K | 313.71K | 717.64K | -370.72K | 723.52K | 117.55K | 259.28K | 24.39K | 119.2K |
Operating Cash Flow | -1.59M | -1.62M | -2.18M | -2.02M | -1.54M | -2.14M | -988.19K | -1.4M | -1.86M | -1.02M | -1.08M | -1.81M | -1.19M | -966.28K | -768.05K | -717.49K | -720.64K |
Capital Expenditures | -7.81K | -15.7K | -5.84K | -833 | -109.61K | -8.79K | -1.95K | -4.91K | -7.59K | -3.47K | -7.24M | -7.25K | -1.93M | n/a | -1.93K | n/a | -712 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 3.15M | -833 | -60.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.64K | n/a | n/a | n/a | n/a |
Investing Cash Flow | -7.81K | -15.7K | -5.84K | -833 | -109.61K | -8.79K | -1.95K | -4.91K | -7.59K | -3.47K | -7.24M | -7.25K | -1.93M | n/a | -1.93K | n/a | -712 |
Debt Repayment | -71.25K | 121.75K | 1.78M | -52.06K | -74.04K | -50.43K | 234.69K | -67.59K | -121.54K | -121.54K | -116.39K | -38.8K | 790K | 2.29M | 1.14M | n/a | 486.5K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -193K | n/a | n/a | n/a | n/a | n/a | n/a | 1.29M | 14.00 | n/a | 17.25K | -7.63K | -370.89K | -6.63K | n/a | n/a |
Financial Cash Flow | 100.03K | 180.19K | 1.9M | 551.68K | 377.14K | 9.13M | 514.63K | 324.36K | 1.6M | -121.52K | -116.39K | 5.17M | 782.37K | 1.92M | 1.13M | n/a | 486.5K |
Net Cash Flow | -1.5M | -1.46M | -287.66K | -1.47M | -1.27M | 6.98M | -475.51K | -1.08M | -270.49K | -1.15M | -1.2M | 3.35M | -409.95K | 957.83K | 364.39K | -717.49K | -234.85K |
Free Cash Flow | -1.6M | -1.64M | -4.2B | -2.02M | -1.65M | -2.15M | -990.14K | -1.41M | -1.87M | -1.02M | -8.32M | -1.82M | -3.12M | -966.28K | -769.99K | -717.49K | -721.35K |